True or False: Neoantigen-based cancer vaccines are designed using tumor-specific mutations identified from a patient's genome.
- True
- False
Answer: True
Neoantigens arise from somatic mutations in tumors; personalized vaccines prime T cells to target them. mRNA platform enables rapid design. Clinical trials show promise in melanoma, glioblastoma. [[ICMR Reports, NCERT Biology Class 12]]